PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

University Hospitals only health system in northeast Ohio offering FDA-approved KISUNLA™ for treatment of Alzheimer’s disease

UH Brain Health & Memory Center begins KISUNLA (Donanemab) infusions for patients

2024-11-20
(Press-News.org) CLEVELAND--University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA™ (donanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer’s disease. UH is the only health system in Northeast Ohio currently offering these infusion treatments. Donanemab has shown promise in clinical trials and may be a treatment option for patients with mild cognitive impairment and mild dementia due to Alzheimer’s disease.

“People with Alzheimer’s disease have an abnormal buildup of plaques in their brain that contain a protein called beta-amyloid. Donanemab is an intravenous medication designed to target and remove these plaques,” explained Rajeet Shrestha, MD, psychiatrist, UH Neurological Institute, and assistant professor at Case Western Reserve University School of Medicine. “As the second FDA-ap­proved treatment to address the potential underlying cause of Alzheimer’s, donanemab therapy has the potential to slow cog­nitive and functional decline if started in the early stages of the disease. We’re happy to be able to offer this breakthrough treatment to patients and provide them and their families with hope as we work towards a cure for this disease.”

Donanemab is administered every four weeks through IV infusion, with each infusion lasting about 30 minutes. Patients are monitored for a period of time, usually about 30 minutes, after each infusion to ensure there are no negative reactions to the drug. The number of infusions is dependent upon the patient: some may be able to stop treatment in as little as six months, while others could receive treatment for up to 12 or 18 months.

“At University Hospitals, we provide comprehensive disease management for our patients including access to the latest treatments available for Alzheimer’s disease,” said Mohamed Elkasaby, MD, neurologist, UH Neurological Institute, and Assistant Professor of Neurology at Case Western Reserve School of Medicine. “Patients with symptoms of early Alzheimer’s and the confirmed presence of beta-amyloid plaques in the brain may be eligible for treatment with donanemab. Although there is no single diagnostic test to confirm Alzheimer’s disease, physicians may use a variety of approaches to help them make a diagnosis and determine if treatment with donanemab might be appropriate.”

Early symptoms of Alzheimer’s may include mild cognitive impairment, such as forgetfulness and confusion, and mild dementia, where people have difficulty performing familiar tasks. To confirm eligibility, tests and procedures for patients may include:

Comprehensive personal and family medical history Mental status tests Physical and neurological exams Blood tests Spinal tap to remove a sample of cerebrospinal fluid for testing MRI of the brain PET scan of the brain to look for the presence of beta-amyloid plaques Donanemab can have side effects, some of which are serious. Patients approved to receive donanemab therapy will be carefully monitored at set intervals as determined by their physician. Subsequent brain MRI’s, EKG’s, and lab tests will be obtained periodically to monitor for ARIA and other serious side effects of treatment.

For more information on the donanemab infusion program, and to learn more about eligibility requirements and potential side effects, call Rebecca DiFranco, RN, Alzheimer's Disease Care Coordinator, UH Brain Health and Memory Center, at 216-464-6203, or visit: https://www.uhhospitals.org/services/neurology-and-neurosurgery-services/conditions-and-treatments/brain-health-and-memory/donanemab-for-alzheimers

UH is also proud to offer an additional FDA-approved treatment option for Alzheimer’s. For more information about LEQEMBI® (lecanemab), visit: https://www.uhhospitals.org/services/neurology-and-neurosurgery-services/conditions-and-treatments/brain-health-and-memory/lecanemab-for-alzheimers

Dr. Elkasaby will discuss both treatment options via a virtual health talk on January 22, 2025. Registration information will be posted, and patients can access additional health talks from UH experts on this site: https://www.uhhospitals.org/health-talks

###

About University Hospitals / Cleveland, Ohio
Founded in 1866, University Hospitals serves the needs of patients through an integrated network of more than 20 hospitals (including five joint ventures), more than 50 health centers and outpatient facilities, and over 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship quaternary care, academic medical center, University Hospitals Cleveland Medical Center, is affiliated with Case Western Reserve University School of Medicine, Northeast Ohio Medical University, Oxford University, Taiwan National University College of Medicine and the Technion Israel Institute of Technology. The main campus also includes the UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, with more than 3,000 active clinical trials and research studies underway. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to 19 Clinical Care Delivery and Research Institutes. UH is one of the largest employers in Northeast Ohio with more than 30,000 employees. Follow UH on LinkedIn, Facebook and Twitter. For more information, visit UHhospitals.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Real-world chemists are more diverse than generative AI images suggest

Real-world chemists are more diverse than generative AI images suggest
2024-11-20
Asking children “What does a scientist look like?” now results in more illustrations of women and people of color than decades ago. But do generative artificial intelligence (AI) tools also depict the diversity among scientists? Researchers reporting in the Journal of Chemical Education prompted AI image generators for portraits of chemists. They found that none of the collections accurately represents the gender, racial or disability diversity among real chemists today. Millions of images are being created by generative AI each day. And the output of these tools is only as good as their algorithms and the initial images used to train ...

Curiosity, images, and scientific exploration

Curiosity, images, and scientific exploration
2024-11-20
When we gaze at nature’s remarkable phenomena, we might feel a mix of awe, curiosity, and determination to understand what we are looking at. That is certainly a common response for MIT’s Alan Lightman, a trained physicist and prolific author of books about physics, science, and our understanding of the world around us.  “One of my favorite quotes from Einstein is to the effect that the most beautiful experience we can have is the mysterious,” Lightman says. “It’s the fundamental emotion that is the cradle of true art and true science.” Lightman explores those concepts in his latest book, “The ...

Nature publishes collection of papers advancing the human cell atlas, with research supported by CZI

2024-11-20
Today, Nature and other Nature Portfolio journals published a collection of more than 40 peer-reviewed papers marking a milestone toward researchers’ understanding of the human body in health and disease and the development of the first draft of the Human Cell Atlas (HCA). The Human Cell Atlas is an international community whose mission is to align groups engaged in creating comprehensive reference maps of all human cells — the fundamental units of life — as a basis for understanding human health and for diagnosing, monitoring, and treating disease. The Chan Zuckerberg Initiative (CZI) is one ...

Researchers catalog the microbiome of US rivers

2024-11-20
Rivers and streams serve as critical connectors across vast geographical landscapes, trickling out of tucked-away headwaters and snaking thousands of miles toward oceans and deep seas. These waterways directly impact human and environmental health, agriculture and energy production, and supply the United States with two-thirds of its drinking water. And yet, compared with other larger waterbodies, the microbiology of rivers is relatively understudied. A Colorado State University-led team of scientists have contributed to changing that — detailing for the first time both broad and specific information ...

Mapping 1.6 million gut cells to find new ways treat disease

Mapping 1.6 million gut cells to find new ways treat disease
2024-11-20
The most comprehensive cell map of the human gut to date has been created by combining spatial and single-cell data from 1.6 million cells. Mapping the cells of the gut can provide us with further insights into what happens in conditions such as bowel cancer and Inflammatory Bowel Disease (IBD). Using this atlas, researchers from the Wellcome Sanger Institute and collaborators uncovered a new role of a specific gut cell, highlighting its contributions to a cycle of inflammation in some individuals, possibly causing pain and distress. The study, published today (20 November) in Nature, details how the team ...

First molecule identified that promotes gut healing while inhibiting tumour progression

2024-11-20
Researchers at Karolinska Institutet have found a molecule that can both help the intestines to heal after damage and suppress tumour growth in colorectal cancer. The discovery could lead to new treatments for inflammatory bowel disease (IBD) and cancer. The results are published in the journal Nature. Many patients with inflammatory bowel disease (IBD) such as Crohn’s disease or ulcerative colitis do not respond to available treatments, highlighting the need to identify novel therapeutic strategies. In a new study published in Nature, researchers propose that promoting ...

Trends in postpartum depression by race, ethnicity, and prepregnancy BMI

2024-11-20
About The Study: In this cross-sectional study, postpartum depression (PPD) diagnosis increased significantly across all racial and ethnic groups and body mass index (BMI) categories over the past decade. While rising PPD may reflect improved screening and diagnosis practices, the persistently high rates highlight the need to develop and implement interventions to prevent the condition while expanding efforts to mitigate the impact of PPD on maternal and child health.  Corresponding Author: To contact the corresponding author, Darios Getahun, MD, PhD, ...

Short-term and long-term mortality risk after preterm birth

2024-11-20
About The Study: The findings of this population-based matched cohort study suggest that individuals born preterm were at an increased risk of death from birth until their third and fourth decades of life, with higher risks as gestational age decreased. Some of these associations may have been partly due to underlying health determinants that affected preterm birth and mortality. These findings suggest that preterm birth should be recognized as a risk factor for mortality and could inform preventive strategies. Corresponding Author: To contact the corresponding author, Asma M. Ahmed, PhD, MD, MPH, email asahmed@wakehealth.edu. To access ...

Thanksgiving special: dinosaur drumsticks and the story of the turkey trot

Thanksgiving special: dinosaur drumsticks and the story of the turkey trot
2024-11-20
New Haven, Conn. — Wings may be the obvious choice when studying the connection between dinosaurs and birds, but a pair of Yale paleontologists prefer drumsticks. That part of the leg, they say, is where fibular reduction among some dinosaurs tens of millions of years ago helped make it possible for peacocks to strut, penguins to waddle, and turkeys to trot. “A good way to understand this is to take a look at drumsticks, like the ones people eat on Thanksgiving,” said Armita Manafzadeh, lead author ...

Superior photosynthesis abilities of some plants could hold key to climate-resilient crops

Superior photosynthesis abilities of some plants could hold key to climate-resilient crops
2024-11-20
LA JOLLA (November 20, 2024)—More than 3 billion years ago, on an Earth entirely covered with water, photosynthesis first evolved in little ancient bacteria. In the following many millions of years, those bacteria evolved into plants, optimizing themselves along the way for various environmental changes. This evolution was punctuated around 30 million years ago with the emergence of a newer, better way to photosynthesize. While plants like rice continued using an old form of photosynthesis known as C3, others like corn and sorghum developed a newer and more efficient version called C4. There are now more than 8,000 different C4 plant ...

LAST 30 PRESS RELEASES:

Study links wind-blown dust from receding Salton Sea to reduced lung function in area children

Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis

Final day of scientific sessions reveals critical insights for clinical practice at AAO-HNSF Annual Meeting and OTO EXPO

Social adversity and triple-negative breast cancer incidence among black women

Rapid vs standard induction to injectable extended-release buprenorphine

Galvanizing blood vessel cells to expand for organ transplantation

Common hospice medications linked to higher risk of death in people with dementia

SNU researchers develop innovative heating and cooling technology using ‘a single material’ to stay cool in summer and warm in winter without electricity

SNU researchers outline a roadmap for next-generation 2D semiconductor 'gate stack' technology

The fundamental traditional Chinese medicine constitution theory serves as a crucial basis for the development and application of food and medicine homology products

Outfoxed: New research reveals Australia’s rapid red fox invasion

SwRI’s Dr. Chris Thomas named AIAA Associate Fellow

National Collegiate Athletic Association (NCAA) funding for research on academic advising experiences of Division I Black/African American student-athletes at minority serving institutions

Johri developing artificial intelligence literacy among undergraduate engineering and technology students

Boston Children’s receives a $35 million donation to accelerate development of therapeutic options for children with brain disorders through the Rosamund Stone Zander and Hansjoerg Wyss Translational

Quantum crystals offer a blueprint for the future of computing and chemistry

Looking beyond speech recognition to evaluate cochlear implants

Tracking infectious disease spread via commuting pattern data

Underweight children cost the NHS as much per child as children with obesity, Oxford study finds.

Wetland plant-fungus combo cleans up ‘forever chemicals’ in a pilot study

Traditional Chinese medicine combined with peginterferon α-2b in chronic hepatitis B

APS and SPR honor Dr. Wendy K. Chung with the 2026 Mary Ellen Avery Neonatal Research Award

The Gabriella Miller Kids First Data Resource Center (Kids First DRC) has launched the Variant Workbench

Yeast survives Martian conditions

Calcium could be key to solving stability issues in sodium-ion batteries

Can smoother surfaces prevent hydrogen embrittlement?

Heart rate changes predict depression treatment success with magnetic brain stimulation

Genetics pioneer transforms global depression research through multi-omics discoveries

MDMA psychiatric applications synthesized: Comprehensive review examines PTSD treatment and emerging therapeutic indications

Psychedelics offer new therapeutic framework for stress-related psychiatric disorders

[Press-News.org] University Hospitals only health system in northeast Ohio offering FDA-approved KISUNLA™ for treatment of Alzheimer’s disease
UH Brain Health & Memory Center begins KISUNLA (Donanemab) infusions for patients